TD Asset Management
GMAB icon

TD Asset Management’s Genmab GMAB Stock Holding History

TD Asset Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-21,171
Closed -$925K – 1512
2021
Q3 		$925K Buy
+21,171
New +$950K ﹤0.01% 1270
2020
Q2 		– Sell
-18,524
Closed -$304K – 1365
2020
Q1 		$304K Buy
18,524
+1,222
+7% +$27.2K ﹤0.01% 1264
2019
Q4 		$284K Sell
17,302
-124
-0.7% -$2.71K ﹤0.01% 1324
2019
Q3 		$286K Buy
+17,426
New +$343K ﹤0.01% 1252

Other funds holding GMAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TD Asset Management's GMAB Position: Q4 2021 in Review

TD Asset Management sold out of Genmab (GMAB) in Q4 2021, closing a stake of 21,171 shares — an estimated $925K sold.

TD Asset Management first reported a position in GMAB in Q3 2019 and held it in 4 quarters. The position peaked at $925K in Q3 2021. 211 funds tracked by Wall St. Rank hold GMAB as of Q4 2021.

  • TD Asset Management reported no remaining Genmab position as of Q4 2021 after selling out during the quarter.
  • TD Asset Management sold 21,171 Genmab shares in Q4 2021, an estimated $925K.
  • TD Asset Management first reported a position in Genmab in Q3 2019 and held it in 4 quarters.
  • TD Asset Management's Genmab position peaked at $925K in Q3 2021.
  • 211 funds tracked by Wall St. Rank held Genmab as of Q4 2021.

Based on TD Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.